202 related articles for article (PubMed ID: 36592162)
1. Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma.
Ali WAS; Huang X; Wu Y; Ma Y; Pan H; Liao J; Yang Z; Hong S; Yang Y; Huang Y; Zhao Y; Fang W; Zhao H; Zhang L
Cancer Control; 2023; 30():10732748221148912. PubMed ID: 36592162
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma.
Li Y; Wang K; Zhao E; Li B; Li S; Dong X; Yuan L; Yang H
Pathol Oncol Res; 2022; 28():1610245. PubMed ID: 35721326
[No Abstract] [Full Text] [Related]
3. Prognostic nutritional index and serum lactate dehydrogenase predict the prognosis of nasopharyngeal carcinoma patients who received intensity-modulated radiation therapy.
Zhang C; Zhan Z; Fang Y; Ruan Y; Lin M; Dai Z; Zhang Y; Yang S; Xiao S; Chen B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17795-17805. PubMed ID: 37934254
[TBL] [Abstract][Full Text] [Related]
4. Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti-Programmed Cell Death 1 Immunotherapy.
Xu JY; Wei XL; Ren C; Zhang Y; Hu YF; Li JY; Chen JL; Wang YQ; Han F; Wang FH
JAMA Netw Open; 2022 Mar; 5(3):e220587. PubMed ID: 35230439
[TBL] [Abstract][Full Text] [Related]
5. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients.
Xiong Y; Shi LL; Zhu LS; Peng G
Ann Palliat Med; 2021 Apr; 10(4):4122-4133. PubMed ID: 33832314
[TBL] [Abstract][Full Text] [Related]
7. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525
[TBL] [Abstract][Full Text] [Related]
8. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
[TBL] [Abstract][Full Text] [Related]
9. Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases.
Ludwig J; Haubold J; Heusner TA; Bauer S; Siveke JT; Richly H; Wetter A; Umutlu L; Theysohn JM
Rofo; 2021 Jun; 193(6):683-691. PubMed ID: 33348383
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of neutrophil-lymphocyte ratio and lactate dehydrogenase in melanoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Zhang Y; Liu B; Kotenko S; Li W
Medicine (Baltimore); 2022 Aug; 101(32):e29536. PubMed ID: 35960066
[TBL] [Abstract][Full Text] [Related]
12. Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma.
Ma Y; Chen X; Wang A; Zhao H; Lin Q; Bao H; Zhang Y; Hong S; Tang W; Huang Y; Yang Y; Wu X; Shao Y; Fang W; Zhang L
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737344
[TBL] [Abstract][Full Text] [Related]
13. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer.
Zhang W; Chen Y; Zhou G; Liu X; Chen L; Tang L; Mao Y; Sun Y; Ma J
Medicine (Baltimore); 2015 Sep; 94(37):e1505. PubMed ID: 26376394
[TBL] [Abstract][Full Text] [Related]
15. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
[TBL] [Abstract][Full Text] [Related]
16. [Effect of pretreatment serum LDH and ALP levels on the prognosis of patients with nasopharyngeal carcinoma].
Zhou JY; Chen T; Li W; Ye K; Wei ZB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(14):1069-1073. PubMed ID: 29798242
[No Abstract] [Full Text] [Related]
17. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
18. Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
Tang LQ; Hu DP; Chen QY; Zhang L; Lai XP; He Y; Xu YX; Wen SH; Peng YT; Chen WH; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mai HQ
PLoS One; 2015; 10(4):e0122965. PubMed ID: 25874450
[TBL] [Abstract][Full Text] [Related]
19. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy.
Jin Y; Ye X; Shao L; Lin BC; He CX; Zhang BB; Zhang YP
Eur J Cancer; 2013 May; 49(7):1619-26. PubMed ID: 23266049
[TBL] [Abstract][Full Text] [Related]
20. A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.
Chen S; Guo S; Gou M; Pan Y; Fan M; Zhang N; Tan Z; Dai G
Front Oncol; 2022; 12():951985. PubMed ID: 36387152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]